Short Interest in Masimo Corporation (NASDAQ:MASI) Declines By 30.0%

Masimo Corporation (NASDAQ:MASI) was the recipient of a significant drop in short interest during the month of March. As of March 13th, there was short interest totaling 2,680,885 shares, a drop of 30.0% from the February 26th total of 3,828,135 shares. Based on an average trading volume of 1,848,469 shares, the days-to-cover ratio is currently 1.5 days. Approximately 6.0% of the company’s shares are short sold.

Institutional Trading of Masimo

Large investors have recently bought and sold shares of the business. Corient Private Wealth LLC raised its holdings in Masimo by 1.2% during the 4th quarter. Corient Private Wealth LLC now owns 340,230 shares of the medical equipment provider’s stock worth $44,250,000 after buying an additional 4,015 shares during the period. Caitong International Asset Management Co. Ltd acquired a new stake in shares of Masimo during the fourth quarter worth $116,000. Pacer Advisors Inc. raised its holdings in shares of Masimo by 21.1% during the fourth quarter. Pacer Advisors Inc. now owns 7,360 shares of the medical equipment provider’s stock worth $957,000 after acquiring an additional 1,280 shares during the period. Virtu Financial LLC bought a new stake in Masimo in the 4th quarter valued at $258,000. Finally, T. Rowe Price Investment Management Inc. boosted its stake in Masimo by 9.6% in the 4th quarter. T. Rowe Price Investment Management Inc. now owns 2,330,158 shares of the medical equipment provider’s stock worth $303,061,000 after purchasing an additional 203,395 shares during the period. 85.96% of the stock is owned by institutional investors.

Masimo Trading Up 0.1%

Shares of MASI stock traded up $0.22 on Friday, hitting $177.11. The stock had a trading volume of 1,134,695 shares, compared to its average volume of 1,987,350. The company has a current ratio of 2.49, a quick ratio of 1.47 and a debt-to-equity ratio of 0.72. Masimo has a twelve month low of $125.94 and a twelve month high of $179.00. The company has a fifty day moving average price of $159.93 and a two-hundred day moving average price of $148.34. The firm has a market cap of $9.51 billion, a P/E ratio of -16.80, a PEG ratio of 1.79 and a beta of 1.21.

Wall Street Analysts Forecast Growth

Several analysts have commented on MASI shares. Weiss Ratings reiterated a “sell (d)” rating on shares of Masimo in a research report on Thursday, January 22nd. Stifel Nicolaus set a $180.00 price target on Masimo in a research report on Tuesday, February 17th. Raymond James Financial cut Masimo from an “outperform” rating to a “market perform” rating in a research note on Friday. BTIG Research lowered Masimo from a “buy” rating to a “neutral” rating in a research note on Wednesday, February 18th. Finally, Wolfe Research cut Masimo from a “strong-buy” rating to a “hold” rating in a report on Thursday, February 19th. Eight research analysts have rated the stock with a Hold rating and one has given a Sell rating to the company. Based on data from MarketBeat, the stock presently has an average rating of “Reduce” and an average price target of $181.17.

About Masimo

Masimo (NASDAQ: MASI) is a global medical technology company specializing in noninvasive monitoring solutions. The company’s flagship technology, Masimo SET® (Signal Extraction Technology), enhances the accuracy of pulse oximetry in challenging clinical conditions. Beyond pulse oximetry, Masimo’s portfolio extends to brain function monitoring, regional oximetry, and acoustic respiration rate monitoring, serving critical, acute, and ambulatory care settings.

In addition to its core monitoring technologies, Masimo offers a range of patient cables, sensors, and connectivity platforms designed to integrate with hospital information systems and remote monitoring applications.